141 related articles for article (PubMed ID: 9763574)
1. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
Saitoh K; Miura I; Takahashi N; Miura AB
Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting.
Miura I; Takahashi N; Kobayashi Y; Saito K; Miura AB
Int J Hematol; 2000 Oct; 72(3):310-7. PubMed ID: 11185986
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
5. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization.
Takahashi N; Miura I; Saitoh K; Miura AB
Blood; 1998 Dec; 92(12):4758-63. PubMed ID: 9845542
[TBL] [Abstract][Full Text] [Related]
6. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
7. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.
Miura I; Kobayashi Y; Takahashi N; Saitoh K; Miura AB
Br J Haematol; 2000 Sep; 110(4):876-9. PubMed ID: 11054073
[TBL] [Abstract][Full Text] [Related]
8. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
[TBL] [Abstract][Full Text] [Related]
9. Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization.
Abruzzese E; Buss D; Rainer R; Rao PN; Pettenati MJ
Leuk Res; 1996 Jul; 20(7):551-7. PubMed ID: 8795688
[TBL] [Abstract][Full Text] [Related]
10. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
11. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization.
Nylund SJ; Verbeek W; Larramendy ML; Ruutu T; Heinonen K; Hallman H; Knuutila S
Cancer Genet Cytogenet; 1993 Oct; 70(2):120-4. PubMed ID: 8242591
[TBL] [Abstract][Full Text] [Related]
12. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
[TBL] [Abstract][Full Text] [Related]
13. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
Voso MT; Hohaus S; Moos M; Haas R
Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
[TBL] [Abstract][Full Text] [Related]
14. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells.
Sawada K; Sato N; Notoya A; Tarumi T; Hirayama S; Takano H; Koizumi K; Yasukouchi T; Yamaguchi M; Koike T
Blood; 1995 Jan; 85(1):194-202. PubMed ID: 7528567
[TBL] [Abstract][Full Text] [Related]
15. Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia.
Gahn B; Schäfer C; Neef J; Troff C; Feuring-Buske M; Hiddemann W; Wörmann B
Blood; 1997 Jun; 89(12):4275-81. PubMed ID: 9192749
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.
Fagioli F; Cuneo A; Bardi A; Carli MG; Bigoni R; Balsamo R; Previati R; Pazzi I; Roberti G; Rigolin GM
Cancer Genet Cytogenet; 1995 Jul; 82(2):116-22. PubMed ID: 7664240
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous occurrence of myelodysplastic syndrome and monoclonal B lymphocytes with a different clonal origin.
Cauwelier B; Nollet F; De Laere E; Van Leeuwen M; Billiet J; Criel A; Louwagie A
Leuk Lymphoma; 2002 Jan; 43(1):191-3. PubMed ID: 11908728
[TBL] [Abstract][Full Text] [Related]
19. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
Soenen V; Fenaux P; Flactif M; Lepelley P; Lai JL; Cosson A; Preudhomme C
Br J Haematol; 1995 Jul; 90(3):701-6. PubMed ID: 7647013
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells.
Span LF; Vierwinden G; Pennings AH; Boezeman JB; Raymakers RA; de Witte T
Exp Hematol; 2005 Apr; 33(4):435-42. PubMed ID: 15781334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]